Effects of the dopamine agonist cabergoline on the pulsatile and TRH-induced secretion of prolactin, LH, and testosterone in male beagle dogs
Introduction
In humans and rats, pituitary prolactin release is both pulsatile and nyctohemeral [1], [2], [3], [4]. Also, in female dogs, a pulsatile secretion pattern for prolactin has been demonstrated [5], while in male dogs a pulsatile secretion of this hormone is only suggested considering spontaneously elevated prolactin concentrations found in individual but not all dogs [6]. The pulsatile secretion of pituitary anterior lobe hormones is governed jointly by hypothalamic inhibitory and stimulatory signals [7]. Dopamine has been recognised as the main inhibitory neural signal in the regulation of prolactin release [8], [9]. The ergot-alkaloid cabergoline is a potent dopamine-2 receptor agonist. Its suppressing effect on prolactin secretion has been clearly demonstrated in the bitch [10].
In addition to the major inhibitory dopaminergic tone, several substances are known to have prolactin-releasing activity. Only a few years ago, a specific prolactin-release promoting peptide has been identified and characterised in the hypothalamus [11], [12]. In addition, several other prolactin-stimulating factors have been reported, such as serotonin [13] and thyrotrophin-releasing hormone (TRH) [14], [15], [16], [17], [18]. In a recent study the strong prolactin stimulating effect of TRH was also demonstrated in cattle in vitro and in vivo when compared with the prolactin release induced by a bovine posterior pituitary extract and prolactin releasing peptide [19]. Nevertheless, the exact role of TRH in the physiological regulation of prolactin secretion and the effect of the dopaminergic tone on TRH-induced prolactin secretion are not completely understood [7].
Several studies indicate an interrelationship of the secretion patterns of prolactin and the gonadotrophins. It has been clearly demonstrated that high concentrations of prolactin inhibit GnRH pulsatility in women [20], [21] and are associated with decreased gonadotrophin secretion in sows [22]. In females, lowering of the plasma concentration of prolactin to basal level is usually associated with the return of gonadotrophic pulsatility [20], [22]. In bitches, administration of dopamine agonists during both the luteal phase and anoestrus results in shortening of the interoestrous interval in the bitch [23], [24], [25], [26]. It has been shown that this dopamine agonist-induced shortening of the interoestrous interval in the bitch is associated with an increase in circulating FSH concentration [27].
Also, in men and male rats excessive release of prolactin leads to suppression of gonadotrophin release, which appears to be due to the action of prolactin on the central nervous system [28]. It has been suggested that prolactin is one of the factors, which regulate the sensitivity of gonadotrophin release to negative testosterone feedback. In hyperprolactinemic men, both LH and testosterone concentrations are reduced, implying increased sensitivity of LH release to negative testosterone feedback [29]. In boars, experimentally induced hyperprolactinemia has been shown to decrease basal LH concentrations without affecting LH pulsatility. The LH decrease was accompanied by an increase in testosterone concentrations [30]. Reduction of serum prolactin concentrations by bromocryptine did, however, not initiate a re-increase in LH concentrations. In contrast, maximum prolactin suppression by bromocryptine in male mice and rats was accompanied by a significant elevation of plasma levels of LH and FSH [31]. It is suggested that a direct stimulatory effect of bromocriptine on testicular steroidogenesis may contribute to its therapeutic effects in hyperprolactinemic men [32]. Data on interaction of prolactin on one hand and the LH-testosterone axis on the other hand are missing in male dogs.
The objective of the present study was to characterise the effects of the dopamine-2 receptor agonist cabergoline on the serum profiles of prolactin, LH, and testosterone in male beagles. In addition, the effects of a single intravenous TRH-injection on the secretion of the three hormones as well as on thyroid-stimulating hormone (TSH) and thyroxine (T4) were studied before and under cabergoline medication.
Section snippets
Experimental design
Eight healthy male beagle dogs (A–H) at the age of 12 months to 6 years were included in the study. The dogs were kept in groups of four in roofed over outdoor kennels provided with two shelter huts each. Animal housing, care and experimentation complied with the animal welfare regulations of Germany.
During the three weeks before the start of the study, the dogs were habituated daily to a separate blood collection room, in order to avoid influences on hormone levels induced by stress resulting
Serum profiles of prolactin, LH and testosterone before and under cabergoline administration
The mean serum prolactin concentration in the first series of blood samples (control) of the eight beagles was 3.0 ± 0.3 (range 2.6–3.5) ng ml−1. Under cabergoline administration, it decreased to 2.9 ± 0.2 (range 2.6–3.2) ng ml−1. The difference was statistically significant (p < 0.05).
The mean serum concentrations of LH and testosterone were similar before and under cabergoline administration [LH: 4.6 ± 1.3 (range 3.2–7.1) ng ml−1 versus 4.4 ± 1.7 (range 2.5–7.7) ng ml−1, testosterone: 2.5 ± 0.9 (range
Discussion
The mean basal prolactin concentrations measured in the eight male beagles were slightly different from those found in other studies. The mean annual prolactin concentration in 16 male mongrel dogs was 4.6 ± 0.8 ng ml−1 [40]. A mean prolactin concentration of 1.7 ± 0.2 ng ml−1 has been reported in a group of six cross-bred and two pure-bred dogs using a commercial homologous endpoint EIA [6]. These may be due to breed peculiarities, differences in sampling frequency (number of samples per time period)
References (47)
- et al.
Secretion of growth hormone and prolactin during progression of the luteal phase in healthy dogs: a review
Mol Cell Endocrinol
(2002) - et al.
Stimulation of prolactin release by prolactin-releasing peptide in rats
Biochem Biophys Res Commun
(1999) - et al.
Thyroid-stimulating hormone response after single administration of thyrotropin-releasing hormone and combined administration of four hypothalamic releasing hormones in beagle dogs
Domest Anim Endocrinol
(1996) - et al.
Prolactin disorders
Fertil Steril
(1997) Prolactin injection, a new contraceptive method: experimental study
Contraception
(1994)- et al.
Spontaneous and GnRH-induced pulsatile LH and testosterone release in pubertal, adult and aging male Beagles
Theriogenology
(1994) - et al.
Low doses of bromocriptine shorten the interestrous interval in the bitch without lowering plasma prolactin concentration
Theriogenology
(2003) - et al.
Human prolactin: 24-hour pattern with increased release during sleep
Science
(1972) - et al.
Unsuppressed prolactin secretion in the male rat is pulsatile
Neuroendocrinology
(1979) - et al.
Pulsatile prolactin secretory patterns throughout the oestrous cycle in the rat
J Endocrinol
(1993)
Mechanisms subserving the physiological nocturnal relative hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency, and interpulse interval. A general clinical research study
J Clin Endocrinol Metab
Secretory patterns of prolactin in dogs: circannual and ultradian rhythms
Reprod Dom Anim
Prolactin secretion and its control
Dopamin: a prolactin-inhibiting hormone
Endocrinol Rev
Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion
Endocrinology
A prolactin-releasing peptide in the brain
Nature
Evidence that serotonin stimulates a prolactin-releasing factor in the rat
Neuroendocrinology
Effect and side of action on hypothalamic neuropeptides on prolactin in sheep
Neuroendocrinology
Regulation of prolactin secretion at the level of the lactotroph
Annu Rev Physiol
Novel aspects of posterior pituitary function: regulation of prolactin secretion
Front Neuroendocrinol
Physiological roles of thyrotropin-releasing hormone and vasoactive intestinal peptide on the pulsatile secretory patterns of prolactin in pituitary-grafted female rats
J Endocrinol
Bovine posterior pituitary extract stimulates prolactin release from the anterior pituitary gland in vitro and in vivo in cattle
Reprod Dom Anim
Cited by (16)
Effects of Cabergoline on Thyroid Hormones and Semen Quality of Dog
2017, Topics in Companion Animal MedicineCitation Excerpt :However, this group believed that cabergoline reduced thyrotropin-releasing hormone (TRH) levels and TRH reduction leads to suppression of hyperprolactinemia in bitches. In 2006, Koch et al10 investigated the effect of cabergoline on secretion of prolactin, TRH, luteinizing hormone (LH), and testosterone in 8 healthy male dogs between 1 and 6 years of age. They indicated that cabergoline has the minimal suppression effect on prolactin concentrations and also has a clear suppression effect on TSH levels.
Pituitary Function
2008, Clinical Biochemistry of Domestic Animals, Sixth EditionEffects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors
2019, Endocrine-Related Cancer